Tertatolol
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Oral |
ATC code | C07AA16 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
|
|
CAS Number | 34784-64-0 |
PubChem (CID) | 36920 |
IUPHAR/BPS | 571 |
ChemSpider | 33875 |
UNII | 9ZO341YQXP |
KEGG | D07182 |
ChEMBL | CHEMBL434200 |
Chemical and physical data | |
Formula | C16H25NO2S |
Molar mass | 295.44 g/mol |
3D model (Jmol) | Interactive image |
Chirality | Racemic mixture |
|
|
|
|
(what is this?) (verify) |
Tertatolol (Artex, Artexal, Prenalex) is a medication in the class of beta blockers, used in the treatment of high blood pressure. It was discovered by the French pharmaceutical company Servier and is marketed in Europe.[1]
Tertatolol has also been shown to act as a 5-HT1A receptor antagonist, similarly to pindolol.[2][3]
See also[edit]
References[edit]
- ^ Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.
- ^ Jolas T, Haj-Dahmane S, Lanfumey L, et al. (May 1993). "(-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain". Naunyn-Schmiedeberg's Archives of Pharmacology. 347 (5): 453–63. doi:10.1007/bf00166735. PMID 7686633.
- ^ Soudijn, W.; Olivier, Berend; Wijngaarden, I. van (1997). Serotonin receptors and their ligands. Amsterdam: Elsevier. ISBN 0-444-82041-8.
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |